Chorioamnionitis primary prevention: Difference between revisions
Jump to navigation
Jump to search
m Changes made per Mahshid's request |
Adnan Ezici (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Chorioamnionitis}} | {{Chorioamnionitis}} | ||
{{CMG}} ; {{AE}} {{Adnan Ezici}} | |||
==Overview== | ==Overview== | ||
Effective measures for the primary prevention of chorioamnionitis include [[induction of labor]] after 34 weeks of gestation and administration of prophylactic [[antimicrobial]] therapy in the presence of [[Premature rupture of membranes|preterm premature rupture of membranes]] (PPROM). | |||
==Primary Prevention== | ==Primary Prevention== | ||
Effective measures for the primary prevention of chorioamnionitis in the presence of [[Premature rupture of membranes|preterm premature rupture of membranes]] include:<ref name="pmid21962477">{{cite journal| author=Fishman SG, Gelber SE| title=Evidence for the clinical management of chorioamnionitis. | journal=Semin Fetal Neonatal Med | year= 2012 | volume= 17 | issue= 1 | pages= 46-50 | pmid=21962477 | doi=10.1016/j.siny.2011.09.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21962477 }} </ref><ref name="pmid20569811">{{cite journal |vauthors=Tita AT, Andrews WW |title=Diagnosis and management of clinical chorioamnionitis |journal=Clin Perinatol |volume=37 |issue=2 |pages=339–54 |date=June 2010 |pmid=20569811 |pmc=3008318 |doi=10.1016/j.clp.2010.02.003 |url=}}</ref> | |||
*[[induction of labor]] after 34 weeks of gestation | |||
*Prophylactic antimicrobial regimen | |||
**Preferred regimen: [[Macrolide]] ([[Erythromycin]] {{or}} [[Azithromycin]]) {{and}} [[Ampicillin]] for 7–10 days (IV for 2 days followed by oral routes) | |||
The use of intrapartum [[ampicillin-sulbactam]] might be an effective measure for the primary prevention of chorioamnionitis in the presence of meconium-stained fluid. | |||
==References== | ==References== | ||
| Line 16: | Line 17: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:NeedsEnglishReview]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 21:36, 12 June 2021
|
Chorioamnionitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chorioamnionitis primary prevention On the Web |
|
American Roentgen Ray Society Images of Chorioamnionitis primary prevention |
|
Risk calculators and risk factors for Chorioamnionitis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Effective measures for the primary prevention of chorioamnionitis include induction of labor after 34 weeks of gestation and administration of prophylactic antimicrobial therapy in the presence of preterm premature rupture of membranes (PPROM).
Primary Prevention
Effective measures for the primary prevention of chorioamnionitis in the presence of preterm premature rupture of membranes include:[1][2]
- induction of labor after 34 weeks of gestation
- Prophylactic antimicrobial regimen
- Preferred regimen: Macrolide (Erythromycin OR Azithromycin) AND Ampicillin for 7–10 days (IV for 2 days followed by oral routes)
The use of intrapartum ampicillin-sulbactam might be an effective measure for the primary prevention of chorioamnionitis in the presence of meconium-stained fluid.
References
- ↑ Fishman SG, Gelber SE (2012). "Evidence for the clinical management of chorioamnionitis". Semin Fetal Neonatal Med. 17 (1): 46–50. doi:10.1016/j.siny.2011.09.002. PMID 21962477.
- ↑ Tita AT, Andrews WW (June 2010). "Diagnosis and management of clinical chorioamnionitis". Clin Perinatol. 37 (2): 339–54. doi:10.1016/j.clp.2010.02.003. PMC 3008318. PMID 20569811.